Form 4 for RGEN REPLIGEN CORP
Accepted 2024-08-01 00:00:00 ET · period of report 2024-08-01 · accession 0000950170-24-089409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-01 | 2024-08-01 | RGEN | MUIR GLENN P | Dir | M - OptEx | $36.29 | +5,000 | 13.3K | +60% | +$181.4K |
| D | 2024-08-01 | 2024-08-01 | RGEN | MUIR GLENN P | Dir | M - OptEx | $0.00 | +5,000 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | M | A | 5,000 | $36.29 | 13,283 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-08-01 | M | A | 5,000 | $0.00 | 0 | D | $36.29 · — to 2025-09-14 | 5,000 Common Stock | (F1) This option is fully vested and exercisable. |